ProCE Banner Activity

Linkage to Care After HBV Diagnosis in Asian Communities in the US

Podcast Episodes
A discussion of barriers to linkage to care after patients in Asian communities are diagnosed with HBV, from the healthcare provider’s and the patient advocate’s perspectives.

Released: November 14, 2022

Expiration: November 13, 2023

No longer available for credit.

Share

Faculty

Mindie H. Nguyen

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine
Department of Gastroenterology and Hepatology
Stanford University Medical Center
Palo Alto, California

Melinda Tran

Melinda Tran

Thuan Vu

Thuan Vu, MD

Jennifer Wild

Jennifer Wild, MS, BSN, RN, OCN

Clinical Nurse
Department of GI Medical Oncology
University of California San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from:

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine
Department of Gastroenterology and Hepatology
Stanford University Medical Center
Palo Alto, California

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD: consultant/advisor/speaker: Exact Science, Gilead, GlaxoSmithKline, Intercept, Laboratory of Advanced Medicine, Lilly; researcher: Exact Science, Gilead, GlaxoSmithKline, Intercept, Laboratory of Advanced Medicine, Lilly.

Melinda Tran,

Melinda Tran has no relevant financial relationships to disclose.

Thuan Vu, MD

Thuan Vu, MD, has no relevant financial relationships to disclose.

Jennifer Wild, MS, BSN, RN, OCN

Clinical Nurse
Department of GI Medical Oncology
University of California San Francisco
San Francisco, California

Jennifer Wild, MS, BSN, RN, OCN: consultant/advisor/speaker: MUH Life Sciences.